Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 3670

1.

The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?

Wo JY, Shipley WU, Dahl DM, Coen JJ, Heney NM, Kaufman DS, Zietman AL.

BJU Int. 2009 Jul;104(2):179-83. doi: 10.1111/j.1464-410X.2008.08299.x. Epub 2008 Dec 23.

2.

Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.

Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T; Cancer Registration Committee of the Japanese Urological Association.

Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.

4.
5.

Management and prognosis of transitional cell carcinoma superficial recurrence in muscle-invasive bladder cancer after bladder preservation.

Pieras E, Palou J, Salvador J, Rosales A, Marcuello E, Villavicencio H.

Eur Urol. 2003 Aug;44(2):222-5; discussoion 225.

PMID:
12875942
6.

Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.

Zietman AL, Grocela J, Zehr E, Kaufman DS, Young RH, Althausen AF, Heney NM, Shipley WU.

Urology. 2001 Sep;58(3):380-5.

PMID:
11549485
7.
8.

Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.

Peyromaure M, Slama J, Beuzeboc P, Ponvert D, Debré B, Zerbib M.

Urology. 2004 Jan;63(1):73-7. Review.

PMID:
14751352
9.

[Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].

Fujimoto K, Chihara Y, Kondo H, Hirao Y.

Hinyokika Kiyo. 2006 Jun;52(6):433-8. Japanese.

PMID:
16848356
10.

T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin.

Volkmer BG, Gschwend JE, Maier SH, Seidl-Schlick EM, Bach D, Romics I.

J Urol. 2003 Mar;169(3):931-4; discussion 934-5.

PMID:
12576815
11.

Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.

Tester W, Caplan R, Heaney J, Venner P, Whittington R, Byhardt R, True L, Shipley W.

J Clin Oncol. 1996 Jan;14(1):119-26.

PMID:
8558186
12.
13.

Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.

George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.

Urology. 2004 Sep;64(3):488-93. Review.

PMID:
15351577
14.

Clinical outcome of high-grade non-muscle-invasive bladder cancer: a long-term single center experience.

Iida S, Kondo T, Kobayashi H, Hashimoto Y, Goya N, Tanabe K.

Int J Urol. 2009 Mar;16(3):287-92. doi: 10.1111/j.1442-2042.2008.02239.x. Epub 2009 Feb 4.

15.

T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy.

De Berardinis E, Busetto GM, Antonini G, Giovannone R, Gentile V.

Int Urol Nephrol. 2011 Dec;43(4):1047-57. doi: 10.1007/s11255-011-9941-x. Epub 2011 Mar 29.

PMID:
21442469
16.

Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.

Lerner SP, Tangen CM, Sucharew H, Wood D, Crawford ED.

J Urol. 2007 May;177(5):1727-31.

PMID:
17437798
17.

Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success.

Lebret T, Gaudez F, Hervé JM, Barré P, Lugagne PM, Botto H.

Eur Urol. 1998;34(1):67-72.

PMID:
9676417
19.

Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?

Weiss C, Wolze C, Engehausen DG, Ott OJ, Krause FS, Schrott KM, Dunst J, Sauer R, Rödel C.

J Clin Oncol. 2006 May 20;24(15):2318-24.

20.

Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma.

Smaldone MC, Jacobs BL, Smaldone AM, Hrebinko RL Jr.

Urology. 2008 Sep;72(3):613-6. doi: 10.1016/j.urology.2008.04.052. Epub 2008 Jun 13.

PMID:
18554696
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk